In-vivo PET imaging of implanted human retinal pigment epithelium cells in a Parkinson's disease rat model

Nuclear Medicine Communications

Volumn 29, Issue 5, 2008, Pages 455-461

  Wang, Ruimin ^a   Zhang, Jinming ^a   Guo, Zhe ^a   Shen, Li ^a   Shang, Aijia ^a   Chen, Yingmao ^a   Yao, Shulin ^a   He, Tingting ^a   Yin, Dayi ^a   Tian, Jiahe ^a  

^a Departments of Nuclear Medicine   (China)

Author keywords

Parkinson's disease; Positron emission tomography; Retinal pigment epithelial cells; Transplantation cell therapy

Indexed keywords

3 BETA(4 FLUOROPHENYL) 2 BETA TROPANECARBOXYLIC ACID METHYL ESTER C 11; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACCUMULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; NONHUMAN; PARKINSON DISEASE; PIGMENT EPITHELIUM; POSITRON EMISSION TOMOGRAPHY; RAT; TREATMENT OUTCOME;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; FEMALE; HUMANS; PARKINSONIAN DISORDERS; PIGMENT EPITHELIUM OF EYE; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 41949135298     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f5d291     Document Type: Article

References (23)

1. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999; 22:123-144.
2. Curt RF. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc Natl Acad Sci USA 2002; 99:1755-1757.
3. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002; 99:2344-2349.
4. Doudet DJ, Cornfeldt ML, Honey CR, Schweikert AW, Allen RC. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Exp Neurol 2004; 189:361-368.
5. Ding W, Bai J, Zhang J, Chen Y, Cao L, He Y, et al. In vivo tracking of implanted stem cells using radio-labeled transferring scintigraphy. Nucl Med Biol 2004; 31:719-725.
6. Marmor MF, Wolfensberger TJ. The Retinal Pigment Epithelium: Function and Disease. New York: Oxford University Press; 1998. pp. 11-12.
7. Opas M, Dziak E. bFGF-induced transdifferentiation of RPE to neuronal progenitors is regulated by the mechanical properties of the substratum. Dev Biol 1994; 161:440-454.
8. Sakaguchi DS, Janick LM, Reh TA. Basic fibroblast growth factor (FGF-2) induced transdifferentiation of retinal pigment epithelium: generation of retinal neurons and glia. Dev Dyn 1997; 209:387-398.
9. Amemiya K, Haruta M, Takahashi M, Kosaka M, Eguchi G. Adult human retinal pigment epithelial cells capable of differentiating into neurons. Biochem Biophys Res Commun 2004; 316:1-5.
10. Bakay RA, Raiser CD, Stover NP, Subramanian T, Cornfeldt ML, Schweikert AW, et al. Implantation of spheramine in advanced Parkinson's disease (PD). Front Biosci 2004; 9:592-602.
11. Thomas J, Wang J, Takubo H, Sheng J, de Jesus S, Bankiewicz KS. A 6-OHDA induced selective Parkinsonian rat model: further biochemical and behavioral characterization. Exp Neurol 1994; 126:159-167.
12. 11C-raclopride biding in rat striatum, quantified using PET. Synapse 1995; 21:45-53.
13. 11C]N-methylspiperone, in rats. Ann Nucl Med 1999; 13:161-167.
14. Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, et al. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model. NeuroImage 2003; 20:1064-1075.
15. 11C]N-methylspiperone. J Nucl Med 2000; 41:65-70.
16. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 2002; 15:991-998.
17. 18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease. Synapse 2004; 51:119-127.
18. Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M, Sakamoto M. Alteration in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for β-CFT binding with positron emission tomography. Ann Neurol 1999; 45:601-610.
19. Nikolaus S, Larisch R, Beu M, Forutan F, Vosberg H, Muller-Gartner HW. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET. Eur J Nucl Med 2003; 30:390-395.
20. Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, et al. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurol Methods 1996; 67:103-112.
21. Hume SP, Brown DJ, Ashworth S, Hirani E, Luthra SK, Lammertsma AA. In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner. J Neurosci methods 1997; 76:45-51.
22. Subramanian T, Marchionini D, Potter EM, Cornfeldt M. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioural deficits without provoking a host immune response. Cell Transplant 2002; 11:207-214.
23. Watts RL, Raiser CD, Stover NP, Cornfeldt ML, Schweikert AW, Allen RC, et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm 2003; 65 (Suppl):215-227.